Contact your GP if you experience significant worsening of diarrhoea or constipation, persistent nausea or vomiting, or severe abdominal pain
Authors reply to Peronard and Mayntz: SGLT2 inhibitors, and how they work beyond the glucosuric effect
Clinical studies revealed an average weight loss of 12.4% at the highest dose, making it suitable for those who prefer an oral option
The following points are a high-level overview, not a complete list of risks or precautions
This is where the natural approach has the greatest evidence-based impact
DOI 10.1007/s40618-025-02792-1 - routine-care cohort, semaglutide arm n=1,393, adjusted -8.83% at 6 months